JP2024178283A5 - - Google Patents

Download PDF

Info

Publication number
JP2024178283A5
JP2024178283A5 JP2024161331A JP2024161331A JP2024178283A5 JP 2024178283 A5 JP2024178283 A5 JP 2024178283A5 JP 2024161331 A JP2024161331 A JP 2024161331A JP 2024161331 A JP2024161331 A JP 2024161331A JP 2024178283 A5 JP2024178283 A5 JP 2024178283A5
Authority
JP
Japan
Prior art keywords
antibody
tau protein
antibody conjugate
carrier
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024161331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024178283A (ja
Filing date
Publication date
Priority claimed from PCT/JP2019/045589 external-priority patent/WO2020105700A1/ja
Application filed filed Critical
Publication of JP2024178283A publication Critical patent/JP2024178283A/ja
Publication of JP2024178283A5 publication Critical patent/JP2024178283A5/ja
Pending legal-status Critical Current

Links

JP2024161331A 2018-11-22 2024-09-18 抗体コンジュゲート Pending JP2024178283A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018219558 2018-11-22
JP2018219558 2018-11-22
PCT/JP2019/045589 WO2020105700A1 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート
JP2020557617A JP7594913B2 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020557617A Division JP7594913B2 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート

Publications (2)

Publication Number Publication Date
JP2024178283A JP2024178283A (ja) 2024-12-24
JP2024178283A5 true JP2024178283A5 (enExample) 2025-03-28

Family

ID=70773827

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020557617A Active JP7594913B2 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート
JP2024161331A Pending JP2024178283A (ja) 2018-11-22 2024-09-18 抗体コンジュゲート

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020557617A Active JP7594913B2 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート

Country Status (5)

Country Link
US (1) US20220018856A1 (enExample)
EP (1) EP3885362A4 (enExample)
JP (2) JP7594913B2 (enExample)
CN (1) CN113166235A (enExample)
WO (1) WO2020105700A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021065306A1 (ja) * 2019-09-30 2021-04-08 ニプロ株式会社 血液試料を検体とするタウタンパク質検出方法
CN113533746B (zh) * 2021-07-22 2022-05-10 深圳市天大生物医疗器械有限公司 一种P-Tau蛋白化学发光检测试剂盒及其制备方法
EP4399524A4 (en) 2021-09-09 2025-10-08 Alzpath Inc PHOSPHO-TAU ANTIBODIES AND METHODS OF USE
CN115015228A (zh) * 2022-02-22 2022-09-06 上海科华生物工程股份有限公司 一种检测血液中p-tau181蛋白的化学发光试剂盒及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69318420T2 (de) 1992-12-14 1999-01-28 Naamloze Vennootschap Innogenetics S.A., Gent Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung
JPH06239899A (ja) * 1993-02-12 1994-08-30 Teijin Ltd ヒトタウ蛋白に対する抗体、並びに該抗体を利用する体液中のヒトタウ蛋白の測定方法
PT737208E (pt) 1993-12-21 2006-12-29 Innogenetics Nv Anticorpos monoclonais específicos para phf-tau, hibridomas que os segregam, reconhecimento de antigénios por estes anticorpos e suas aplicações
JP5247963B2 (ja) * 2000-01-24 2013-07-24 インノジェネティクス・エヌ・ブイ タウオパチーの診断
US7534427B2 (en) * 2002-12-31 2009-05-19 Immunomedics, Inc. Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
WO2011109112A2 (en) 2010-03-05 2011-09-09 Albert Einstein College Of Medicine Of Yeshiva University Method of detecting tau protein and tau fragments in serum
GB201112056D0 (en) * 2011-07-14 2011-08-31 Univ Leuven Kath Antibodies
WO2014011972A1 (en) * 2012-07-13 2014-01-16 Bristol-Myers Squibb Company Tau immunoassay
JP2017512056A (ja) * 2014-02-10 2017-05-18 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． ヒト・タウに結合する抗体および該抗体を使用してヒト・タウを定量するためのアッセイ
CA2983034A1 (en) * 2015-04-17 2016-10-20 Igm Biosciences, Inc. Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof

Similar Documents

Publication Publication Date Title
JP2024178283A5 (enExample)
CN111704666A (zh) 新型冠状病毒n蛋白的配对单克隆抗体及其应用
RU2009143671A (ru) Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков
CN102746374A (zh) 肽、该肽的用途和生产方法以及固定有该肽的固相和其生产方法
JP2008503720A5 (enExample)
CN104246504A (zh) A型流感病毒的检测试剂盒
CN103045541A (zh) 杂交瘤细胞株及其产生的抗人心脏型脂肪酸结合蛋白的单克隆抗体
JPH04232462A (ja) アンギオテンシンｉｉの特異的検定のためのキット
CN112851803A (zh) 抗h10亚型禽流感病毒血凝素蛋白单克隆抗体zju10-01及其应用
CN112175072A (zh) 抗h5亚型禽流感病毒血凝素蛋白单克隆抗体zju5-01及其应用
CN101165491B (zh) 以金磁微粒为载体检测抗双链dna抗体的方法
JP2001041961A (ja) ＨＩＶ−１ｐ２４抗原の免疫測定方法及び試薬
CN110996986B (zh) Hcv抗原的多表位融合蛋白及其用途
JP3374101B2 (ja) Ｅｎｖ／ｇａｇポリペプチドマーカーを使用するネコ免疫不全ウイルス感染の診断
CN114994330A (zh) 检测抗HSP 90-beta-IgG自身抗体的试剂盒及其应用
WO1995025172A1 (fr) Fragments d'anticorps recombinants synthetises et biotinyles dans e. coli, leur utilisation en immunodosages et en purification par immunoaffinite
CN113563484B (zh) 一种G11-scFv-Nluc双功能活性的融合蛋白及其应用
JP2837669B2 (ja) Ｔ−細胞リンパ趨行性ウイルス蛋白及びその分析
CN109470855B (zh) 肺癌早期诊断用蛋白芯片及试剂盒
CN115932255A (zh) 一种山羊痘病毒抗体荧光微球免疫层析检测试剂盒及其制备方法
CN114895023A (zh) 检测抗Talin-1-IgG自身抗体的试剂在制备检测血管内皮损伤的试剂盒中的应用
CN114994308A (zh) 一种检测抗Desmoglein 1-IgG抗体的试剂盒
CN114924081A (zh) 神经母细胞分化相关蛋白-IgG在制备血管内皮损伤试剂盒中的应用
JPH01153960A (ja) 赤血球凝集アッセイ
Lauritzen et al. Peptide dot immunoassay and immunoblotting: Electroblotting from aluminum thin‐layer chromatography plates and isoelectric focusing gels to activated nitrocellulose